Education
About Us
Working with TipRanks
Follow Us
Voyager Therapeutics (VYGR)
NASDAQ:VYGR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 80.00M | $ 250.01M | $ 40.91M | $ 37.41M | $ 171.13M |
| Gross Profit | $ 80.00M | $ 157.84M | $ -14.86M | $ -36.37M | $ 62.38M |
| Operating Income | $ -83.29M | $ 122.01M | $ -50.84M | $ -73.62M | $ 27.38M |
| EBITDA | $ -78.56M | $ 126.45M | $ -39.65M | $ -68.45M | $ 31.20M |
| Net Income | $ -65.00M | $ 132.33M | $ -46.41M | $ -71.20M | $ 36.74M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 266.68M | $ 230.88M | $ 118.85M | $ 132.54M | $ 181.14M |
| Total Assets | $ 393.05M | $ 351.28M | $ 159.36M | $ 193.85M | $ 261.58M |
| Total Debt | $ 43.73M | $ 20.29M | $ 23.13M | $ 44.18M | $ 47.61M |
| Net Debt | $ -27.64M | $ -48.51M | $ -75.83M | $ -73.25M | $ -56.83M |
| Total Liabilities | $ 93.29M | $ 114.96M | $ 100.34M | $ 98.80M | $ 107.26M |
| Stockholders' Equity | $ 299.76M | $ 236.32M | $ 59.02M | $ 95.06M | $ 154.32M |
| Cash Flow | |||||
| Free Cash Flow | $ -18.83M | $ 74.66M | $ -15.00M | $ -55.13M | $ -108.81M |
| Operating Cash Flow | $ -15.31M | $ 77.92M | $ -12.51M | $ -53.52M | $ -96.72M |
| Investing Cash Flow | $ -94.86M | $ -141.64M | $ -7.34M | $ 65.91M | $ 113.00M |
| Financing Cash Flow | $ 114.02M | $ 33.65M | $ 1.11M | $ 612.00K | $ 3.16M |